» Articles » PMID: 34494309

Chronic Actinic Dermatitis in an Old Adult Significantly Improved by Dupilumab

Overview
Date 2021 Sep 8
PMID 34494309
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature.

Vanhaecke C, Viguier M Acta Derm Venereol. 2024; 104:adv40453.

PMID: 39175450 PMC: 11358845. DOI: 10.2340/actadv.v104.40453.


Successful Treatment of Chronic Actinic Dermatitis with Tofacitinib.

Zhong J, Ali K, Yang P, Zhao X, Wu L Clin Cosmet Investig Dermatol. 2024; 17:399-407.

PMID: 38352065 PMC: 10863493. DOI: 10.2147/CCID.S451824.


The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series.

Chen J, Yu N, Wu W, Ou S, Chen Q, Zhu H Clin Cosmet Investig Dermatol. 2023; 16:2357-2363.

PMID: 37663886 PMC: 10474848. DOI: 10.2147/CCID.S422683.


Dupilumab in Inflammatory Skin Diseases: A Systematic Review.

Olbrich H, Sadik C, Ludwig R, Thaci D, Boch K Biomolecules. 2023; 13(4).

PMID: 37189381 PMC: 10136243. DOI: 10.3390/biom13040634.


Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature.

Chen J, Li H, Zhu H Clin Cosmet Investig Dermatol. 2022; 14:1913-1917.

PMID: 35002273 PMC: 8722565. DOI: 10.2147/CCID.S342401.